|会社名||Elanco Animal Health Inc （ELAN エランコ･アニマル･ヘルス）|
|業種||医薬品 医療関連（Health Care）|
|概要||事業概要 エランコ･アニマル･ヘルス(Elanco Animal Health Incorporated)はコンパニオンとフード･アニマル向け製品を開発、製造、販売する動物健康会社である。同社はコンパニオン･アニマル疾患予防、コンパニオン･アニマル･セラピューティックス、フード･アニマル･フューチャータンパク質･健康、およびフード･アニマル反芻動物･豚などの4種類で製品を提供する。同社は虫、ノミおよびダニからペットを守る製品とともに、徴候、種および製剤に基づいてコンパニオン･アニマル･セクターに各種寄生虫駆除剤ポートフォリオを提供する。同社はまた、種、行動様式、適応症および病期にわたる疼痛および変形性関節症ポートフォリオを提供する。また、耳炎（耳感染症）、心臓血管および皮膚科の適応症も提供する。フード･アニマル･フューチャータンパク質･健康カテゴリーのポートフォリオにはワクチン、栄養酵素、動物専用抗生物質が含まれる。同社はまた、家禽や養殖生産の製品を提供する。 エランコ・アニマル・ヘルスは米国の動物向け医薬品メ―カ―。コンパニオンアニマル、畜産及び水産用の医薬品、ワクチン、飼料用製品の開発・製造・販売を手掛ける。主にペット、魚、肉牛、乳牛、鶏、豚のための寄生虫駆除薬、治療薬、食品・補助食品、抗菌剤、衛生製品、飼料添加物、混合飼料などをグロ―バルに提供する。本社所在地はインディアナ州グリ―ンフィ―ルド。 Elanco Animal Health Incorporated is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, it is committed to helping its customers improve the health of animals in their care, while also making a meaningful impact on its local and global communities. It is driven by its vision of Food and Companionship Enriching Life and our Elanco Healthy Purpose™ Sustainability/ESG Pledges - all to advance the health of animals, people and the planet.|
|代表者氏名||R. David Hoover|
|代表者役職名||Chairman of the Board|
|決算概要||決算概要 BRIEF: For the fiscal year ended 31 December 2018 Elanco Animal Health Inc revenues increased 6% to $3.07B. Net income before extraordinary items totaled $86.5M vs. loss of $343.8M. Revenues reflect United States segment increase of 8% to $1.48B International segment increase of 4% to $1.58B. Net Income reflects Severance and other decrease of 90% to $15.5M (expense) Integration decrease of 71% to $26.5M (expense).|
Highly Unusual Volume Spikes: Amyris, Inc. (NASDAQ:AMRS -4.83%), Elanco Animal Health Incorporated (NYSE:ELAN 3.89%) 2023/01/05 14:59:58 Stock Equity
Amyris, Inc. (AMRS) with the stream of -4.83% also noticed, India Elanco Animal Health Incorporated (ELAN) encountered a rapid change of 3.89% in the last hour of Wednesday’s trading session. … The post Highly Unusual Volume Spikes: Amyris, Inc. (NASDAQ:AMRS -4.83%), Elanco Animal Health Incorporated (NYSE:ELAN 3.89%) appeared first on Stocks Equity .
Elanco to Participate in the 41st Annual J.P. Morgan Healthcare Conference 2023/01/03 13:00:00 Business Wire
GREENFIELD, Ind.--(BUSINESS WIRE)--Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 41st Annual J.P. Morgan Healthcare Conference on Tuesday, January 10, 2023. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts at 12:45 p.m. ET. A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days. ABOUT ELANCO Elanco Animal Health (
Is Elanco Animal Health Incorporated (NYSE:ELAN) stock a better investment at this time? 2022/12/22 17:40:00 US Post News
Elanco Animal Health Incorporated (ELAN)’s stock has witnessed a price declined of -5.71% from the previous close with its current price standing at $11.31. Its current price is -61.85% under its 52-week high of $29.66 and -0.18% more than its 52-week low of $11.34. Based on the past 30-day period, the stock price is -14.73% […]
Sachem Head Capital Management LP Lowers Stake in Elanco to 2% 2022/12/22 12:33:01 Investing.com
Veterinary Pain Management Global Market Report 2022: Ukraine-Russia War Impact 2022/12/21 20:34:00 GlobeNewswire
Major players in the veterinary pain management market are CH Boehringer Sohn AG & Co KG, Zoetis Inc, Merck & Co Inc, Elanco Animal Health Incorporated, Ceva Santé Animale, Vetoquinol SA, Norbrook Laboratories Inc, Dechra Pharmaceuticals PLC, Chanelle Pharma, IDEXX Laboratories Inc, Assisi Animal Health, Bayer AG, Eli Lilly and Company, Novartis AG, and The International Veterinary Academy of Pain Management. Major players in the veterinary pain management market are CH Boehringer Sohn AG & Co KG, Zoetis Inc, Merck & Co Inc, Elanco Animal Health Incorporated, Ceva Santé Animale, Vetoquinol SA, Norbrook Laboratories Inc, Dechra Pharmaceuticals PLC, Chanelle Pharma, IDEXX Laboratories Inc, Assisi Animal Health, Bayer AG, Eli Lilly and Company, Novartis AG, and The International Veterinary Academy of Pain Management.
Elanco oral diabetes therapy for cats granted FDA approval 2022/12/08 20:46:14 Seeking Alpha
The FDA announced Thursday the approval of Bexacat tablets developed by Elanco Animal Health (ELAN) for diabetes mellitus in cats. Read the full story here.
FDA approves first oral treatment for cats with a type of diabetes 2022/12/08 17:22:25 Reuters
The U.S. Food and Drug Administration (FDA) on Thursday approved Elanco Animal Health Inc''s drug for cats with a type of diabetes, making it the first oral drug to be approved for the disease in animals.
Is the Elanco Animal Health Incorporated (NYSE:ELAN) stock an investment opportunity? 2022/11/30 18:16:00 US Post News
In the current trading session, Elanco Animal Health Incorporated’s (ELAN) stock is trading at the price of $12.24, a fall of -0.04% over last night’s close. So, the stock is trading at a price that is -59.44% less than its 52-week high of $30.19 and 8.03% better than its 52-week low of $11.34. Based on […]
Leawood woman sues animal health giants Bayer and Elanco, claiming Seresto flea collar killed her dog 2022/11/23 19:57:33 Business Journals
A lawsuit in federal court in Kansas could determine whether Seresto flea-and-tick collars are causing pet injuries and deaths, despite claims that they are safe for use on pets.
Watch this stock’s price performance: Elanco Animal Health Incorporated (NYSE:ELAN) 2022/11/23 17:48:00 US Post News
Elanco Animal Health Incorporated (ELAN)’s stock is trading at $12.47 at the moment marking a rise of 0.40% from the last session close. As of this writing, shares are priced at -61.32% less than their 52-week high of $32.24, and 10.01% over their 52-week low of $11.34. Based on the past 30-day period, the stock […]
Veterinary Healthcare Market to Witness Huge Growth by 2028 : Zoetis, Ceva, Virbac 2022/07/25 18:07:00 SBWire
Veterinary Healthcare Market 2022-2028 New Jersey, NJ -- ( SBWIRE ) -- 07/25/2022 -- The Latest research study released by HTF MI "Veterinary Healthcare Market" with 100+ pages of analysis on business Strategy taken up by key and emerging industry players and delivers know how of the current market development, landscape, technologies, drivers, opportunities, market viewpoint and status. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Some of the Major Companies covered in this Research are Boehringer Ingelheim, Zoetis, Elanco Animal Health, Bayer Animal Health, Merck Animal Health, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol, Meiji, Ouro Fino Saude, Animalcare Group & Parnell etc. Click here for free sample + related graphs of the report @: https://www.htfmarketreport.com/sample-report/3703959-veterinary-healthcare-market-1 Browse market information, tables and figures extent in-depth TOC on "Veterinary Healthcare Market by Application (Companion Animals & Livestock Animals), by Product Type (, Medicines, Vaccine & Other), Business scope, Manufacturing and Outlook – Estimate to 2027". for more information or any query mail at firstname.lastname@example.org At last, all parts of the Veterinary Healthcare Market are quantitatively also subjectively valued to think about the Global just as regional market equally.
IDEXX upgraded, Elanco downgraded as Goldman shakes up animal health coverage 2022/07/21 13:48:59 Seeking Alpha
Goldman Sachs has upgraded IDEXX Laboratories (IDXX) and downgraded Elanco Animal Health (ELAN) as the analysts led by Nathan Rich updated their coverage on animal healthcare industry in…
Goldman Sachs Downgrades Elanco Animal Health to Sell 2022/07/21 07:44:04 Investing.com
Elanco Confirms Date and Conference Call for Second Quarter 2022 Financial Results Announcement 2022/07/18 10:30:00 Wallstreet:Online
Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2022 financial results on Monday, August 8, 2022. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company’s performance. The conference call will begin at 8:00 a.m. eastern time. Investors, media, and the general public can access a live webcast
The 3 Best Pet Stocks to Buy Now 2022/07/04 15:00:31 InvestorPlace
During the pandemic, many Americans got pets to keep them company when the lockdowns forced people to stay at home. Surveys and common sense indicate that most people will keep their new pets. With pets having become an integral part of millions of more American families, many companies are benefiting financially. Investors can hop on that trend by buying the best pet stocks. As someone who works from home, doesn’t have children, and has two pets, I can attest that pets can certainly help fill the social void caused by a lack of physically present co-workers and children. I can also tell you that pets can be somewhat costly. All together, the food, health care, health insurance, grooming, and pet sitting services my wife and I purchase for our dog, Dallas, and our cat, Strawberry, are far from cheap. So, companies are making a great deal of money from us and from the millions of other pet owners out there. 7 Warren Buffett Stocks to Buy and Hold for the Next Decade Three of the best pet stocks to buy benefit from Americans’ increased spending on their pets.
関連キーワード （医薬品 米国株 ELAN エランコ･アニマル･ヘルス ELAN ）